Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal immunization using recombinant plant-based oral vaccines.

Stephen J Streatfield1

  • 1Applied Biotechnology Institute, 101 Gateway Boulevard, Suite 100, College Station, TX 77845, USA. sstreatfield@appliedbiotech.org

Methods (San Diego, Calif.)
|January 25, 2006
PubMed
Summary

Edible recombinant plant-based vaccines offer a cost-effective strategy for inducing mucosal immunity. Plant expression systems protect antigens from degradation, simplifying vaccine delivery and storage for broad accessibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Production of the High Value Pharmaceutical Target, Human Granulocyte-Colony Stimulating Factor, in Nicotiana benthamiana Is Improved by Co-Expression of the Transcriptional Regulator of the Unfolded Protein Response, bZIP60.

Plant biotechnology journal·2026
Same author

The Nicotiana benthamiana Biofactory.

Plant biotechnology journal·2026
Same author

Basic leucine zipper transcription activators - tools to improve production and quality of human erythropoietin in Nicotiana benthamiana.

Biotechnology journal·2024
Same author

Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate.

Vaccine·2022
Same author

Facilitating viral vector movement enhances heterologous protein production in an established plant system.

Plant biotechnology journal·2022
Same author

Optimization of biomass and target protein yield for Phase III clinical trial to evaluate Angiotensin Converting Enzyme 2 expressed in lettuce chloroplasts to reduce SARS-CoV-2 infection and transmission.

Plant biotechnology journal·2022

Area of Science:

  • Biotechnology
  • Immunology
  • Vaccinology

Background:

  • Mucosal immunity is crucial for protection against pathogens entering through mucosal surfaces.
  • Oral vaccine delivery is cost-effective but faces challenges like gastrointestinal proteolysis.
  • Plant-based vaccine systems offer a promising solution to overcome these delivery hurdles.

Purpose of the Study:

  • To explore the potential of edible recombinant plant materials for oral vaccine delivery.
  • To investigate methods for protecting antigens and enhancing immunogenicity in plant-based vaccines.
  • To assess the feasibility of plant-produced vaccines for human and animal applications.

Main Methods:

  • Expressing vaccine antigens in plants using nuclear or plastid transgenes, or plant viruses.

Related Experiment Videos

  • Employing molecular strategies to optimize antigen expression and post-translational modification.
  • Developing methods for oral delivery, including direct consumption of plant tissues or purified antigens.

    • Main Results:

    • Successful expression of numerous vaccine antigens in various plant systems.
    • Demonstrated stability of plant-stored antigens at ambient temperatures, reducing cold-chain requirements.
    • Advancements in antigen stabilization and delivery strategies, with some candidates entering clinical trials.

    Conclusions:

    • Plant-based vaccine production is a scalable and economical approach for inducing mucosal immunity.
    • Edible vaccines can overcome limitations of traditional oral delivery methods.
    • Plant-produced vaccines show significant potential for widespread use in human and animal health.